Q3 2010

Filed Feb 4, 2011 · 10-Q · 35 days after period end · 0001144204-11-006071

Q3 2010 · 10-Q

Revenue

$2.31M

no prior Q3 2009 on file

Net Income

-$2.23M

no prior Q3 2009 on file

EPS Diluted

-$0.08

no prior Q3 2009 on file

Gross Profit$1,149,000—

Operating Income

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2010 · filed Feb 4, 2011 · 35 d after period end

Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR